{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-048611","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2024-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.374510+00:00","generated_at":"2026-05-29T07:58:34.313503+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ainos signs non-binding MOU with Taiwan Tanabe for VELDONA manufacturing and Taiwan market","bullets":["Non-binding MOU with Taiwan Tanabe Seiyaku (Mitsubishi Tanabe subsidiary) for exclusive marketing, manufacturing, and marketing authorization of VELDONA in Taiwan.","Exclusive right of first negotiation for 3 months from Nov 27, 2024, extendable by 3 months with mutual written notice.","License fees, milestones, and profit-sharing to be agreed in future definitive agreement, contingent on VELDONA NDA approval in Taiwan.","VELDONA is low-dose oral interferon-alpha for Sjögren's syndrome; prior studies showed symptom alleviation and good safety profile.","Ainos believes partnership will accelerate global market entry; Sjögren's syndrome market projected billions in 5 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-048611","json":"https://secwatch.observer/filing/0001493152-24-048611.json","markdown":"https://secwatch.observer/filing/0001493152-24-048611.md","text":"https://secwatch.observer/filing/0001493152-24-048611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224048611/0001493152-24-048611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224048611/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T07:58:34.313503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}